Purchase Order HT001424P0033
Award Date
12/29/23
Potential Completion Date
6/12/24
Potential Value
$22K
Federal Agency
Defense Health Agency
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $10,377.28, is for the purchase of unspecified Illumina sequencing systems, reagents, and consumables. The award has no set-aside designation. Illumina has been awarded multiple previous prime contracts and sub-awards from federal agencies like the NIH,...
This is a firm fixed price delivery order award to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute. The $56,235.00 award is for the provision of reagents and consumables to support genomic sequencing and analysis, with a completion date of May 18, 2024. Illumina has a history of providing sequencing systems, reagents, and related services to support research and...
This is a firm fixed-price delivery order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $872,996.22 award is for the provision of Illumina reagent kits to support genomic analysis and sequencing work. This order falls under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy's Bureau of Medicine and...
This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The award, valued at $135,908.52, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and bioinformatics...
This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis solutions. The $129,148.82 contract provides Illumina sequencing systems, reagents, consumables, and associated services to support genomic research and diagnostics at the National Institute of Environmental Health Sciences. This award is not set-aside and is part of a larger Indefinite...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $15,807.96 award provides Illumina's proprietary sequencing systems, reagents, and services to support nucleic acid sequencing needs, with no set-aside designation. The order is part of a larger Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, valued up...
This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. The order is for $75,832.10 and does not have a set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and consumables, is providing products and services to support genomic sequencing and analysis, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and bioinformatics support....
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $147,003.32 contract is for the provision of various Illumina sequencing systems, reagents, and services to support genomic sequencing and analysis. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $3.3 million that Illumina holds with the Department of the Navy Bureau of...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,198.05 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis work. Illumina has a history of providing similar products and services to federal agencies like the NIH,...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $111,693.06 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics...